The Mechanism of Human Umbilical Mesenchymal Stem Cells (HUMSC) on Biological Behavior of Human Papillomavirus (HPV) Cells Through Restraining the Programmed Cell Death Protein 1/Programmed Cell Death Ligand 1 (PD-1/PD-L1) Signal Pathway

被引:0
作者
Wang, Min [1 ]
Zhu, Yanong [2 ]
Li, Tongmin [2 ]
Xia, Chaofeng [3 ]
机构
[1] Liaocheng Univ, Sch Med, Liaocheng 252003, Shandong, Peoples R China
[2] Matern & Child Hlth Care Hosp, Liaocheng 252004, Shandong, Peoples R China
[3] Liaocheng Peoples Hosp, Dept Anorectal, Liaocheng 252004, Shandong, Peoples R China
关键词
HUMSC; PD-1/PD-L1; HPV; Biological Behavior; Immunologic Escape; CANCER; PD-L1; IMMUNOTHERAPY;
D O I
10.1166/jbt.2022.2884
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Biological behavior of HPV cell was observed by HUMSC through restraining PD-1/PD-L1 signal pathway. And HUMSC was adopted as target cell for the treatment on HPV. The rat HPV model was established and divided into three groups including blank group, control group and test group according to different reagents being injected into rats. Use HE staining method to observe the cancerous transformation of tumor tissue sections. The gene presentation of PD-1/PD-L1 and lymphocyte was detected with Western blot. The invasion and migration condition of cancer cells was observed from experiment in vitro. The quantity of cancer cells in test group was the least. And invasion and migration ability in test group was the weakest. The control group was the second. The number of tumor cells in the blank group was the largest. Strongest ability to invade and migrate. The presentation of PD-L1 was restrained partly by HUMSC. The increasing of immune-associated cells could be prompted by HUMSC. The quantity of CD3(+), CD4(+) and CD8(+) in PB was the most in test group. The expression of blank groups is the lowest than others restrained by HUMSC. And quantity of abundant immune cells including CD3(+), CD4(+) and CD8(+) could be activated partly through activating immune action of body. And monitoring function of immune system on HPV cells could be increased effectively. The invasion and migration ability in vitro of HPV could be reduced partly.
引用
收藏
页码:265 / 272
页数:8
相关论文
共 29 条
[1]   Human umbilical cord mesenchymal stem cell-derived extracellular vesicles: A novel therapeutic paradigm [J].
Abbaszadeh, Hossein ;
Ghorbani, Farzaneh ;
Derakhshani, Mehdi ;
Movassaghpour, Aliakbar ;
Yousefi, Mehdi .
JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (02) :706-717
[2]   Anti-inflammatory and antioxidant effects of mesenchymal and hematopoietic stem cells in a rheumatoid arthritis rat model [J].
Abdelmawgoud, Hanan ;
Saleh, Asmaa .
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (07) :873-880
[3]   High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions [J].
Allouch, Soumaya ;
Malki, Ahmed ;
Allouch, Asma ;
Gupta, Ishita ;
Vranic, Semir ;
Al Moustafa, Ala-Eddin .
FRONTIERS IN ONCOLOGY, 2020, 10
[4]   Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups [J].
Andrews, Lawrence P. ;
Yano, Hiroshi ;
Vignali, Dario A. A. .
NATURE IMMUNOLOGY, 2019, 20 (11) :1425-1434
[5]   Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization [J].
Chang, Hyeyoon ;
Hong, Jin Hwa ;
Lee, Jae-Kwan ;
Cho, Hyun Woong ;
Ouh, Yung Taek ;
Min, Kyung Jin ;
So, Kyeong A. .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (03)
[6]   WNT/β-Catenin signaling pathway regulates non-tumorigenesis of human embryonic stem cells co-cultured with human umbilical cord mesenchymal stem cells [J].
Chang, Yu-Hsun ;
Chu, Tang-Yuan ;
Ding, Dah-Ching .
SCIENTIFIC REPORTS, 2017, 7
[7]   Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells Labeled with Mn2+ and Gd3+ Co-Doped CuInS2-ZnS Nanocrystals for Multimodality Imaging in a Tumor Mice Model [J].
Chetty, Shashank Shankar ;
Praneetha, Selvarasu ;
Murugan, Arumugam Vadivel ;
Govarthanan, Kavitha ;
Verma, Rama Shanker .
ACS APPLIED MATERIALS & INTERFACES, 2020, 12 (03) :3415-3429
[8]   Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia [J].
Curley, Jacob ;
Conaway, Mark R. ;
Chinn, Zachary ;
Duska, Linda ;
Stoler, Mark ;
Mills, Anne M. .
MODERN PATHOLOGY, 2020, 33 (06) :1182-1192
[9]   PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy [J].
Dermani, Fatemeh K. ;
Samadi, Pouria ;
Rahmani, Golebagh ;
Kohlan, Alisa K. ;
Najafi, Rezvan .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) :1313-1325
[10]   Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer [J].
Dorta-Estremera, Stephanie ;
Hegde, Venkatesh L. ;
Slay, Ravaen B. ;
Sun, Rachel ;
Yanamandra, Ananta, V ;
Nicholas, Courtney ;
Nookala, Sita ;
Sierra, Gloria ;
Curran, Michael A. ;
Sastry, K. Jagannadha .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)